Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
BING NEWS:
  • Instant pleasure: Vivus ED pill wins faster-acting 'on demand' label
    The FDA on Thursday approved a revised label for Vivus' erectile dysfunction pill Stendra. Auxilium, which won marketing rights to Stendra in a deal that could be worth as much as $300 million, can now market the drug for use 15 minutes before sex rather ...
    09/17/2014 - 1:00 pm | View Link
  • FDA Approval: End of Arena, VIVUS Running Out of Adrenaline?
    Arena Pharmaceuticals (NASDAQ:ARNA) and VIVUS Inc. (NASDAQ:VVUS), the two companies that have recently gained FDA approval for their weight-loss drugs – the first such drugs approved by the FDA this millennium – were celebrating their wins. But ...
    07/31/2012 - 1:41 am | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:32 pm | View Link
  • Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval
    Law360, New York (April 27, 2012, 8:00 PM EDT) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ...
    04/27/2012 - 1:00 pm | View Link
  • Vivus Weight-Loss Pill Wins Backing of FDA Panel
    Advisers to the Food and Drug Administration voted 20-2 Wednesday that Qnexa’s benefits outweigh its risks at a meeting at agency headquarters in Silver Spring, Maryland. The FDA isn’t required to follow the panel’s recommendation. The agency is ...
    02/22/2012 - 4:41 am | View Link
  • More
BING SEARCH:
  • UPDATE 1-Eli Lilly defeats Teva appeal over Alimta cancer drug
    5 Mins Ago. FRANKFURT, March 22- With rivals joining forces all around, Germany's BASF has been eyeing a surprise foray into generic pesticides, although the issue is ...
    03/24/2017 - 4:31 am | View Website
  • FierceBiotech
    Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.
    03/23/2017 - 9:21 pm | View Website
  • Today's Stock Market News and Analysis
    Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more.
    03/23/2017 - 6:41 am | View Website
  • Marketing | FiercePharma
    The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…
    03/22/2017 - 11:53 pm | View Website
  • Stock Quote ACHN Achillion Pharmaceuticals, Inc.
    Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune ...
    03/22/2017 - 10:10 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News